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Binding of MVL-2 virus, whose envelope lipids were radioactively labeled, to A. laidlawii
JAI cells was determined and characterized. The binding followed first-order kinetics and was
temperature-dependent. All MVL-2 particles were capable of binding to A. laidlawii cells. At
least 75 percent of radioactive MVL-2 bound represented specific binding which was markedly
inhibited by EDTA. Virus infectivity was not essential for binding as inactivation of the virus
by ultraviolet irradiation did not affect binding. Nevertheless, protein denaturing agents or
proteolytic enzymes markedly inhibited MVL-2 binding, suggesting that the binding site of
MVL-2 is of proteinaceous nature.
INTRODUCTION
The MVL-2 Acholeplasma viruses are unique among viruses of procaryotes in
that they are spherical, envelope-bound viruses [1,2] that contain supercoiled, cir-
cular, double-stranded DNA [3]. The envelope of MVL-2 is composed of a lipid
bilayer derived from the host cell membrane [4,5] and several proteins [4,6] of
which at least two are localized on the external surface of the viral envelope [4]
Enveloped viruses, like other viruses, replicate by diverting the biosynthetic
pathways of the host cells to virus production. To gain access to this machinery the
viral genomes must enter the cell cytoplasma. Although little is known of the
mechanism of such entry [7], it is apparent that it should include two major steps:
(1) the binding of the virus through specific binding sites to their receptors on the
host cell membrane, and (2) the penetration of the viral genome through the mem-
brane barrier. The specific receptors for MVL-2 on the external surface of A.
laidlawii cells were recently identified as the oligosaccharide chain of the lipoglycan
molecules [8]. As glycoproteins were not detected in the MVL-2 envelope, the bind-
ing site is expected to be one of the proteins projected on the external surface. This
binding protein would play a major role in recognition and attachment of the virus
to the host cell. As a first step toward characterizing and defining this binding pro-
tein, we are devising an experimental system in which binding can be determined
quantitatively under defined conditions.
MATERIALS AND METHODS
MVL-2 virus was grown on A. laidlawii JAI cells and purified as previously de-
scribed [4]. For labeling the virus 0.25 ,tCi/ml of[9,10-3H] oleic acid (60 Ci/mole) or
0.2 ytCi/ml of [methyl-3H]thymidine was added to the growth medium. The purified
virus was suspended in 0.1 M NaCl in 0.01 M Tris buffer pH 7.5 (TN buffer) to a
concentration of -1 x 1011 plaque-forming units/ml (PFU) and stored at -70°C
until used.
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Assessment ofMVL-2 Binding
MVL-2 binding to A. laidawii JAI cells was assayed using an overnight A.
laidawii JAl culture (A640 = 0.25). The cells were harvested, washed once in 0.25 M
NaCl, and resuspended to an absorbance of A,.. = 10 (-5 x 109 CFU/ml) in
the reaction buffer containing 0.25 NaCl; 0.05 Tris; 0.01 M glucose; 0.0002 M CaCl;
2.5 mg/ml bovine serum albumin and DNase (10Ag/ml) adjusted to pH 7.5. To 0.6
ml samples ofthe cell suspension, aliquots of0.2 ml freshlythawed labeled virus and
0.1 ml of the reaction buffer were added, and the mixtures were incubated for 15
minutes at 37°C. Controls in which A. laidlawii cells were replaced by 0.6 ml ofthe
reaction buffer were included. After incubation, 0.4 ml samples in duplicate were
pipetted on to the surface of silicone oil (0.2 ml) in 1.5 ml plastic microfuge tubes
and centrifuged at 12,800 g for two minutes. Under these conditions, only virus
bound to cells passed through the silicone oil, forming a pellet at the bottom of the
tube. The unbound virus particles remained in the supernatant. After both the
aqueous phase and the oil were removed by suction, the tip of the plastic tube (con-
taining the virus-cell pellet) was cut off with a razor blade, placed in scintillation li-
quor, and counted. Binding results were expressed as 3H-labeled virus bound (cpm)
or as percentage binding obtained by determining the level of radioactivity in the
pellet compared to that in the total reaction mixture.
RESULTS AND DISCUSSION
Kinetics ofMVL-2 Binding to A. laidlawii Cells and the Effect of Temperature
Binding of MVL-2 to A. laidlawii cells was determined using 3H-oleate labeled
virus. The results were identical to those obtained with 3H-thymidine labeled virus
preparations, ruling out the possibility that the radioactivity found in the cell pellet
of reaction mixtures containing 3H-oleate labeled virus was due to the exchange of
the 3H-labeled lipid between the viral envelope and A. laidlawii membranes. Fur-
thermore, in several experiments, the binding capacity determined from radioactiv-
ity measurements was found to be in good correlation with the number of plaque-
forming units (PFU) bound. The number of bound PFU particles was calculated by
subtracting the number of residual PFU left in the supernatant fluid after the cell-
virus complexes had been pelleted from the total PFU in the reaction mixture.
The binding of MVL-2 to A. laidlawii cells follows first-order kinetics. Binding
rates were rapid and temperature-dependent. Maximal binding at 230 and 37°C was
obtained after five minutes ofincubation and did not change significantly on further
incubation for up to 120 minutes at the same temperatures. Binding at 15° and 4°C
reached levels similar to those obtained at 37°C, but those levels were reached after
15 minutes and 45 minutes of incubation, respectively. Subsequent binding experi-
ments were performed for 15 minutes at 37°C.
Binding Specificity ofMVL-2
Figure 1 shows that the binding of 3H-labeled MVL-2 virus was competitively in-
hibited by unlabeled virus. As 100-fold excess of unlabeled virus binding was in-
hibited by 75-80 percent, it seems that 75-80 percent ofthe labeled MVL-2 bound to
A. laidlawii cells represents specific binding and 20-25 percent nonspecific binding.
When the unlabeled virus was allowed to bind to A. laidlawii cells before the
radioactive MVL-2 was added, binding of the labeled virus was more pronouncedly
inhibited (insert, Fig. 1). Thus, when equal amounts (PFU/ml) of labeled and
unlabeled virus were added simultaneously, the binding of 3H-labeled virus was in-




















FIG. 1. Competitive inhibition of
3H-labeled MVL-2 binding to A. laid-
lawii cells by unlabeled virus. Labeled
virus (1 x 109 PFU/ml) was added
simultaneously with 0.1 to 100-fold
excess of unlabeled virus, and binding
was assayed as described in Materials
and Methods. Insert: Time course of
binding of 3H-labeled MVL-2 to A.
Laidlawii cells in the presence (closed
symbols) or absence (open symbols)
of equal amounts of unlabeled virus.
The unlabeled virus was added to-
gether (i); 2.5 minutes before (A); or
5 minutes before the labeled virus (*).
hibited by about 45 percent, whereas when the unlabeled virus was added 2.5 or 5
minutes before the addition ofthe labeled virus, 80 percent inhibition was observed.
Binding as a Function of the Amount ofMVL-2 Virus and A. laidlawii Cells
Figure 2a shows that binding of MVL-2 to a constant amount ofA. laidlawii cells
(2 x 109 CFU/ml) obeys first-order kinetics. The binding increased linearly with the
increase in PFU in the binding mixture, reaching maximal levels at about 5 x 101°
PFU/ml. The ratio of bound MVL-2 virus to A. laidlawii cells at the plateau was
1.5-2 (PFU/CFU). Hence, the amount of MVL-2 used in most binding assays was
chosen to be within the linear region. When the amount of virus was kept constant













FIG. 2. Binding of MVL-2 toA. laid-
50 2 lawii cells as a function of the amount
z of infectious MVL-2 particles (PFU)
o in the binding mixture containing
25 N 2 x 109 CFU/ml of A. laidlawii cells
> (a), or as a function of the number of
viable A. laidlawii cells (CFU) in the
0 binding mixture containing 2 x 1010
PFU/ml of MVL-2 (b).
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high as 98 percent were obtained (Fig. 2b), suggesting that practically all infective
MVL-2 particles are capable of binding to A. laidlawii host cells.
Effect ofDivalent Cations on Binding
The addition of Mg2 or Ca2l to the binding mixture at concentrations of up to 5
mM did not affect the binding of MVL-2 to A. laidlawii cells. Nevertheless, in the
presence of2 mM ethylenediaminetetraacetic acid (EDTA) thebinding was inhibited
by about 70 percent (Table 1), suggesting that the levels of divalent cations present
within MVL-2 or A. Iaidlawii cells are sufficient to ensure optimal binding. The
binding inhibition obtained by EDTA was completely restored by the addition of 5
mM of Ca2", Mg2", or Mn2. The extent of MVL-2 binding in the presence of these
cations was unaffected by the anions used (C1- vs. So42-). To rule out the possibility
that the inhibitory effect of EDTA was due to the release of loosely bound compo-
nent(s) from the viral surface or the A. laidlawii cell membrane, MVL-2 and A.
laidlawii preparations were pretreated with EDTA for 30 minutes at 37°C. As is ap-
parent from Table 2, in binding mixtures containing Mg2', no significant differences
were found in the binding capacity between pretreated and untreated preparations.
The results strongly suggest that the inhibition obtained with EDTA is directly
related to chelating of divalent cations required for binding.
Binding ofMVL-2 Exposed to Various Treatments
Treating MVL-2 preparations by heating, ultraviolet irradiation, proteolytic en-
zymes, or urea resulted in a marked decrease in the infectivity of the preparations.
Yet the effect of such treatments on the binding capacity of the virus varied (Table
2). Thus, after ultraviolet inactivation MVL-2 retained its capacity to bind to A.
laidlawii cells, whereas inactivating MVL-2 by means which cause protein damage,
such as heat or proteolytic enzymes, markedly inhibited the binding, apparently by
damaging the binding sites. These results support the concept that the MVL-2 bind-
ing site(s) is ofproteinaceous nature [9]. The high binding capacity retained by urea-
treated virus preparations may suggest that the specific protein species removed by
the urea treatment does not participate in the binding process. One cannot exclude,
however, the possibility that the high binding levels obtained with urea-treated
TABLE I
Effect of EDTA and MgCI2 on MVL-2 Binding to A. laidlawii JAI Cells
EDTA and MgCl2 in
Preparations Binding Mixture
A. laidlawii EDTA MgCI MVL-2 Bound
MVL-2 Virus Cells (2 mM) (5 mM) (o of Control)
Untreated Untreated 100
Untreated Untreated - + 98
Untreated Untreated + + 32
Untreated Untreated + + 94
Pretreated Untreated + + 96
with 2 mM EDTA
Untreated Pretreated - + 92
with 2 mM EDTA
Pretreated Pretreated - + 96
with 2 mM EDTA with 2 mM EDTA
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TABLE 2
Binding Capacity of MVL-2 Virus Exposed to Various Treatments
Infectivity MVL-2 Bound
Treatmenta (PFU/ml) (% of Control)b
None 1.7 x 1010 100.0
Heat (°C)
45 1.0 x 1010 94.6
65 1.0 x 103 40.0
Ultraviolet Irradiation (minutes)
1 2.0 x 1010 96.4
10 1.0 X 103 88.2
Proteolytic Enzymes (10 Ag/ml)
Trypsin 8.5 x 10' 32.1
Chemotrypsin ND 23.4
Urea (7.5 M) 3.0 x 106 92.8
aMVL-2 virus suspended in TN buffer were treated either by heat (30 minutes at the
temperatures shown), irradiated by an ultraviolet lamp (Mineralight V41 0.25A) at a
distance of 20 cm for 1-10 minutes, treated with proteolytic enzymes for 30 minutes
at 37°C, or with 7.5 M urea for 30 minutes at 4°C.
bBinding values of untreated cells served as controls. Of the control cell population,
34 percent bound to host A. laidlawii cells.
MVL-2 are in fact due to the formation of MVL-2 aggregates upon treatment. Such
aggregates may bind only through a few viral particles, whereas the radioactivity
level will be artificially high, representing all viral particles in the aggregate.
ACKNOWLEDGEMENT
This work was supported by a grant from the Israel Academy of Sciences and Humanities.
REFERENCES
1. Gourlay RN: Mycoplasmatales virus-laidlawii 2, a new virus isolated fromAcholeplasma laidlawii. J
Gen Virol 12:65-67, 1971
2. Gourlay RN, Garwes DJ, Bruce J, et al: Further studies on the morphology and composition of
mycoplasmatales virus laidlawii 2. J Gen Virol 18:127-133, 1973
3. Nowak JA, Maniloff J: Physical characterization of the superhelical DNA genome of an enveloped
mycoplasmavirus. J Virol 29:374-380, 1979
4. Greenberg N, Rottem S: Composition and molecular organization of lipids and proteins in the
envelope of mycoplasmasvirus MVL2. J Virol 32:717-726, 1979
5. Al-Shammari AJN, Smith P: Lipid composition of two mycoplasmaviruses, MV-Lg-L172 and
MVL-2. J Gen Virol 54:455-458, 1981
6. Putzrath RM, Cadden SP, ManiloffJ: Effect ofcell membrane composition on the growth and com-
position of nonlytic enveloped mycoplasmavirus. Virology 106:162-167, 1980
7. Lenard J: Virus envelopes and plasma membranes. Ann Rev Biophys Bioeng 7:139-165, 1978
8. Al-Shammari AJN, Smith PF: Interaction of mycoplasma virus type 2 with cellular components of
Acholeplasma laidlawaii strain JAI. J Virol 36:120-124, 1980
9. Rottem S, Greenburg N: Molecular organization and selective solubilization of lipids and proteins in
the envelope of mycoplasmavirus MVL-2. Rev Infect Dis 4:99-104, 1982